Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Grant or award Chief Operating Officer acquired 19,500 shares (grant or award)
  2. 4 Grant or award VP, Chief Accounting Officer acquired 6,000 shares (grant or award)
  3. 4 Grant or award President and Chief Executive acquired 41,250 shares (grant or award)
  4. 4 Open-market sale 10% owner sold 1,000,001 shares at an average $20.85 ($20,850,019)
  5. 4 Open-market sale Director sold 18,000 shares at an average $32.58 ($586,395)
  6. 4 Open-market sale Director sold 18,000 shares at an average $32.63 ($587,351)
  7. 4 Open-market sale Director sold 18,000 shares at an average $31.25 ($562,538)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale 10% owner sold 2,609 shares at $35.05 ($91,445)
  10. 4 Open-market sale 10% owner sold 8,326 shares at an average $35.16 ($292,727)
  11. 4 Open-market sale Director sold 40,000 shares at an average $34.05 ($1,361,941)
  12. 4 Open-market sale 10% owner sold 24,501 shares at an average $35.49 ($869,427)
  13. 4 Open-market sale 10% owner sold 11,048 shares at an average $35.14 ($388,199)
  14. 4 Open-market sale 10% owner sold 9,394 shares at an average $35.31 ($331,671)
  15. 4 Open-market sale 10% owner sold 8,703 shares at an average $35.11 ($305,571)
  16. 4 Open-market sale 10% owner sold 2,826 shares at $35.06 ($99,080)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale 10% owner sold 3,293 shares at an average $35.19 ($115,883)
  19. 4 Open-market sale 10% owner sold 2,364 shares at an average $35.05 ($82,853)
  20. 4 Open-market sale 10% owner sold 4,300 shares at $35.18 ($151,274)

Page 8 of 12 · 224 filings